Cargando…
Advance in plasma SEPT9 gene methylation assay for colorectal cancer early detection
This review article summarizes the research advances of the plasma-based SEPT9 gene methylation assay for the clinical detection of colorectal cancer and its limitations. Colorectal cancer is a common malignancy with a poor prognosis and a high mortality, for which early detection and diagnosis are...
Autores principales: | Wang, Yu, Chen, Pei-Min, Liu, Rong-Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767789/ https://www.ncbi.nlm.nih.gov/pubmed/29375744 http://dx.doi.org/10.4251/wjgo.v10.i1.15 |
Ejemplares similares
-
Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer
por: Church, Timothy Robert, et al.
Publicado: (2014) -
Performance Comparison Between Plasma and Stool Methylated SEPT9 Tests for Detecting Colorectal Cancer
por: Liu, Yi, et al.
Publicado: (2020) -
Combined
SEPT9
and
BMP3
methylation in plasma for colorectal cancer early detection and screening in a Brazilian population
por: Lima, Adhara Brandão, et al.
Publicado: (2023) -
Plasma-Methylated SEPT9 for the Noninvasive Diagnosis of Gastric Cancer
por: Zhao, Luyao, et al.
Publicado: (2022) -
Aberrant DNA Methylation of SEPT9 and SDC2 in Stool Specimens as an Integrated Biomarker for Colorectal Cancer Early Detection
por: Zhao, Guodong, et al.
Publicado: (2020)